WhitTier Trust Company’s Exelixis EXEL Stock Holding History

WhitTier Trust Company’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-61	Closed	-$1K	–	1013
2018 Q4	$1K	Buy	+61	New	+$1.09K	﹤0.01%	1030

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

WhitTier Trust Company's EXEL Position: Q1 2019 in Review

WhitTier Trust Company sold out of Exelixis (EXEL) in Q1 2019, closing a stake of 61 shares — an estimated $1K sold.

WhitTier Trust Company first reported a position in EXEL in Q4 2018 and held it in 1 quarter. The position peaked at $1K in Q4 2018. 377 funds tracked by Wall St. Rank hold EXEL as of Q1 2019.

WhitTier Trust Company reported no remaining Exelixis position as of Q1 2019 after selling out during the quarter.
WhitTier Trust Company sold 61 Exelixis shares in Q1 2019, an estimated $1K.
WhitTier Trust Company first reported a position in Exelixis in Q4 2018 and held it in 1 quarter.
WhitTier Trust Company's Exelixis position peaked at $1K in Q4 2018.
377 funds tracked by Wall St. Rank held Exelixis as of Q1 2019.

Based on WhitTier Trust Company's 13F filing for Q1 2019, filed 29 Apr 2019.